Using data from automated dispensing units to identify adverse drug reactions-Reference-Cited by-同舟云学术

Using data from automated dispensing units to identify adverse drug reactions

Published:2005-11-15 Issue:22 Volume:62 Page:2397-2400
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

McIntosh Shadreka T.¹,Petropoulos Jerilyn B.²

Affiliation:

1. CVS PatientCARE Network, Largo, FL; at the time of this study she was a Pharm.D. student, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee

2. Medication Information, Miami Veterans Affairs Medical Center, Miami, FL

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/62/22/2397/28324082/ajhp2397.pdf

Reference10 articles.

1. ASHP guidelines on adverse drug reaction monitoring and reporting

2. Hospital Admissions Resulting from Preventable Adverse Drug Reactions

3. Comparison of voluntary adverse drug reaction reports and corresponding medical records

4. Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports

5. Nature of preventable adverse drug events in hospitals: a literature review

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Women's perception of the menopause and hormone treatment: barriers against hormone therapy;Climacteric;2011-02

2. Automated detection of harm in healthcare with information technology: a systematic review;BMJ Quality & Safety;2010-07-29

3. Long-Term Effect of the Women's Health Initiative Study on Antiosteoporosis Medication Prescribing;Journal of Women's Health;2010-05

4. ASHP Guidelines on the Safe Use of Automated Dispensing Devices;American Journal of Health-System Pharmacy;2010-03-15

5. Bioassays for Estrogenic Activity: Development and Validation of Estrogen Receptor (ERα/ERβ) and Breast Cancer Proliferation Bioassays to Measure Serum Estrogenic Activity in Clinical Studies;ASSAY and Drug Development Technologies;2009-02